Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study.
Rebold N, Alosaimy S, Pearson JC, Dionne B, Taqi A, Lagnf A, Lucas K, Biagi M, Lombardo N, Eudy J, Anderson DT, Mahoney MV, Kufel WD, D'Antonio JA, Jones BM, Frens JJ, Baumeister T, Geriak M, Sakoulas G, Farmakiotis D, Delaportas D, Larew J, Veve MP, Rybak MJ. Rebold N, et al. Infect Dis Ther. 2024 Mar;13(3):565-579. doi: 10.1007/s40121-024-00933-2. Epub 2024 Mar 1. Infect Dis Ther. 2024. PMID: 38427289 Free PMC article.
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure.
Rebold N, Lagnf AM, Alosaimy S, Holger DJ, Witucki P, Mannino A, Dierker M, Lucas K, Kunz Coyne AJ, El Ghali A, Caniff KE, Veve MP, Rybak MJ. Rebold N, et al. Microbiol Spectr. 2023 Feb 14;11(1):e0264722. doi: 10.1128/spectrum.02647-22. Epub 2023 Jan 9. Microbiol Spectr. 2023. PMID: 36622246 Free PMC article.
Impact of Ceftolozane-Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections.
Holger DJ, Rebold NS, Alosaimy S, Morrisette T, Lagnf A, Belza AC, Coyne AJK, El Ghali A, Veve MP, Rybak MJ. Holger DJ, et al. Among authors: rebold ns. Infect Dis Ther. 2022 Oct;11(5):1965-1980. doi: 10.1007/s40121-022-00687-9. Epub 2022 Sep 1. Infect Dis Ther. 2022. PMID: 36048335 Free PMC article.
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
Alosaimy S, Lagnf AM, Hobbs ALV, Mubarez M, Kufel WD, Morrisette T, Polisetty RS, Li D, Veve MP, Simon SP, Truong J, Finch N, Venugopalan V, Rico M, Amaya L, Yost C, Cubillos A, Chandler E, Patch M, Smith IMK, Biagi M, Wrin J, Moore WJ, Molina KC, Rebold N, Holger D, Kunz Coyne AJ, Jorgensen SCJ, Witucki P, Tran NN, Davis SL, Sakoulas G, Rybak MJ. Alosaimy S, et al. Among authors: rebold n. Clin Infect Dis. 2023 Feb 8;76(3):e1444-e1455. doi: 10.1093/cid/ciac670. Clin Infect Dis. 2023. PMID: 35982631
Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19.
Rebold N, Alosaimy S, Morrisette T, Holger D, Lagnf AM, Ansari I, Belza AC, Cheaney L, Hussain H, Herbin SR, Abdul-Mutakabbir J, Carron C, Sandhu A, Chopra T, Rybak MJ. Rebold N, et al. Infect Dis Ther. 2022 Jun;11(3):1281-1296. doi: 10.1007/s40121-022-00636-6. Epub 2022 May 11. Infect Dis Ther. 2022. PMID: 35538335 Free PMC article.
Panacea or oversimplification: Relating AUC and troughs.
Rebold N, Lodise T, Rybak MJ. Rebold N, et al. Am J Health Syst Pharm. 2022 Jun 7;79(12):1019-1021. doi: 10.1093/ajhp/zxac031. Am J Health Syst Pharm. 2022. PMID: 35136952 No abstract available.
13 results